US Mono-Isopropanolamine (MIPA) prices in November 2025 were stable, the market remained balanced and buyers were quiet. Domestic demand was subdued as most of the spring-season needs were closed out by the agrochemical blenders, spot inquiries in November were very limited. The buying of water-treatment slowed with the seasonal slowdown and fiscal year-end budget closures. Demand for electronic-grade solvents increased driven by growth in semiconductor applications; however, volumes were not sufficient to offset weakness in the broader industrial sector. The export trade to Canada and Mexico was steady under contract while Brazil remains quiet with still high inventories from previous imports. IPA feedstock prices weakened slightly but were mostly stable, supporting costs. Short term MIPA price is anticipated to be steady unless major changes of feedstock or seasonal demand are witnessed.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
